Skye Bioscience logo

Skye Bioscience

SKYE | NASDAQ
Chart Builder DCF Calculator
$1.06
-$0.03 (-2.75%)
At close: Nov 16, 2026, 4:00 PM ET
$1.08
+$0.02 (+1.82%)
After-hours: Nov 16, 2026, 7:59 PM ET
-2.75%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
26.2
-16.0 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #896/1021 (Top 88%)

Key Statistics

Market Data

Market Cap $5.26M
1D Range
1.03 1.25
52W Range
0.69 11.20

Valuation (TTM)

PE -0.14
PB 3.87
EV/EBITDA -0.01

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $15.00
Loading financial charts...

Profile

Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. I...

Sector Healthcare
Industry Biotechnology
Employees 2
IPO Date Jan 6, 2015
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.